← 返回

具有终末耗竭表型的 TIM-3(+) CD8 T 细胞在血液系统恶性肿瘤中保留功能能力

英文原题:TIM-3(+) CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies.

查看英文原题

TIM-3(+) CD8 T cells with a terminally exhausted phenotype retain functional capacity in hematological malignancies.

PubMed 2024/04/19(内容时间) Sci Immunol Q1 · IF 16.4(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

慢性抗原刺激被认为会导致CD8 T细胞功能障碍。在此,我们在骨髓肿瘤微环境中鉴定出一个CD8 T细胞亚群,尽管其表型看似为终末耗竭(T PHEX),却表达颗粒酶、穿孔素和IFN-γ。同步的基因表达和DNA可及性分析显示,编码这些功能蛋白的基因与BATF表达及基序可及性相关。IFN-γ + T PHEX能有效杀伤骨髓瘤,其效力与短暂效应细胞相当,且疾病进展与IFN-γ + T PHEX数量减少相关。我们还在靶向CD19的CAR-T 细胞中观察到IFN-γ + T PHEX,其能杀伤CD19 + 白血病细胞。IFN-γ + T PHEX基因特征在包括骨髓瘤和淋巴瘤在内的人类癌症的T EX细胞中得以重现。在此,我们描述了血液恶性肿瘤中一个T EX亚群,其矛盾地保留了功能,且不同于慢性病毒感染中发现的失能T EX。因此,IFN-γ + T PHEX代表血液癌症免疫治疗的一个潜在靶点。

展开英文摘要原文

Chronic antigen stimulation is thought to generate dysfunctional CD8 T cells.

Here, we identify a CD8 T cell subset in the bone marrow tumor microenvironment that, despite an apparent terminally exhausted phenotype (T PHEX ), expressed granzymes, perforin, and IFN-γ. Concurrent gene expression and DNA accessibility revealed that genes encoding these functional proteins correlated with BATF expression and motif accessibility. IFN-γ + T PHEX effectively killed myeloma with comparable efficacy to transitory effectors, and disease progression correlated with numerical deficits in IFN-γ + T PHEX .

We also observed IFN-γ + T PHEX within CD19-targeted chimeric antigen receptor T cells, which killed CD19 + leukemia cells. An IFN-γ + T PHEX gene signature was recapitulated in T EX cells from human cancers, including myeloma and lymphoma.

Here, we characterize a T EX subset in hematological malignancies that paradoxically retains function and is distinct from dysfunctional T EX found in chronic viral infections.

Thus, IFN-γ + T PHEX represent a potential target for immunotherapy of blood cancers.

论文信息

作者
Minnie SA、Waltner OG、Zhang P、Takahashi S、Nemychenkov NS、Ensbey KS、Schmidt CR、Legg SRW
单位
Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.United States
文献类型
美国 NIH 资助研究 · 非美国政府资助研究
期刊
Science immunology2024 Apr 19
原文标识
PubMed 38640253 · DOI 10.1126/sciimmunol.adg1094